Erlotinib and pulmonary embolism 
Erlotinib and pulmonary embolism Patient Reports February 11, 2012
Erlotinib Side Effects Report #5407463-3
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on July 19, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: international normalised ratio decreased, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.Erlotinib Side Effects Report #5427701-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: international normalised ratio decreased, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.Erlotinib Side Effects Report #5979438-7
Erlotinib side effect was reported by a Physician from GERMANY on Nov 13, 2008. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with GEMCITABINE, ESOMEPRAZOLE MAGNESIUM, NOVALGIN, IBUPROFEN, FRAXIPARIN. Patient recovered.Erlotinib Side Effects Report #6000656-6
Erlotinib side effect was reported by a Physician from GERMANY on Nov 25, 2008. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cytogenetic abnormality, pulmonary embolism
. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with GEMCITABINE, ESOMEPRAZOLE MAGNESIUM, NOVALGIN, IBUPROFEN, FRAXIPARIN, ZOFRAN, TRAIMTEREN COMP, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6022313-2
Erlotinib side effect was reported by a Physician from GERMANY on Dec 10, 2008. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, unevaluable event. Erlotinib dosage: (100 MG), ORAL. During the same period patient was treated with GEMCITABINE, ESOMEPRAZOLE MAGNESIUM, NOVALGIN, IBUPROFEN, FRAXIPARIN, ZOFRAN, TRAIMTEREN COMP, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5417958-4
Erlotinib side effect was reported by a Physician from UNITED STATES on July 31, 2007. Male patient, 52 years of age, weighting 172.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pulmonary embolism
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, ATIVAN, CELEXA, COLACE, MIRALAX, MLD SOLUTION. Patient recovered.Erlotinib Side Effects Report #6055027-3
Erlotinib side effect was reported by a Physician from FRANCE on Jan 07, 2009. Female patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac disorder, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, ZOFRAN, METOCLOPRAMIDE. Patient died.Erlotinib Side Effects Report #5385085-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, 66 years of age, weighting 166.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung infiltration, oxygen saturation decreased, pneumonia
, procedural complication, pulmonary embolism . Erlotinib dosage: 100MGM EVERY DAY ORAL. Patient died on 06/27/2007.Erlotinib Side Effects Report #5397312-4
Erlotinib side effect was reported by a Physician from GERMANY on July 06, 2007. Female patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, venous thrombosis. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5800749-X
Erlotinib side effect was reported by a Health Professional from UNITED KINGDOM on June 16, 2008. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE, LANSOPRAZOLE, METOCLOPRAMIDE, APREPITANT. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5616731-1
Erlotinib side effect was reported by a Physician from GERMANY on Jan 21, 2008. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac disorder, pulmonary embolism
. Erlotinib dosage: 150 MG, (QD); ORAL. During the same period patient was treated with CAPECITABINE, PREDNISONE, PANTOPRAZOLE, TORSEMIDE, SPIRONOLACTONE, MITAMIZOLE. Patient died on 08/14/2007.Erlotinib Side Effects Report #5670023-3
Erlotinib side effect was reported by a Physician from GERMANY on Feb 29, 2008. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac disorder, pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CAPECITABINE, PREDNISOLONE, PANTOPRAZOLE, TORSEMIDE, SPIRONOLACTONE, MITAMIZOLE. Patient died on 08/14/2007.Erlotinib Side Effects Report #5301498-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5324240-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: metastases to lung, pleural effusion, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient died on 04/04/2007.Erlotinib Side Effects Report #4928557-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, diarrhoea, dyspnoea, pleural effusion, pneumonia
, pulmonary embolism . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6140500-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 25, 2009. Female patient, 54 years of age, weighting 172.6 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, venous thrombosis limb. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with ARQ, ZITHROMAX, ATIVAN, AMBIEN CR, TESSALON, FISH OIL, PRILOSEC, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5300167-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Male patient, 80 years of age, weighting 173.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pain in extremity, pulmonary embolism
, sinus tachycardia. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with GEMCITABINE, GLIMEPIRIDE, GLYBURIDE, SIMVASTATIN, VICODIN, LYRICA, PEPCID AC, SENOKOT. Patient recovered.Erlotinib Side Effects Report #5312964-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Male patient, 80 years of age, weighting 173.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pain in extremity, pulmonary embolism
, sinus tachycardia. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with GEMCITABINE, GLIMEPIRIDE, GLYBURIDE, SIMVASTATIN, VICODIN, LYRICA, PEPCID AC, SENOKOT. Patient recovered.Erlotinib Side Effects Report #5306618-6
Erlotinib side effect was reported by a Physician from FRANCE on Apr 02, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with GLICLAZIDE, IRBESARTAN, ALMOR. Patient died on 11/15/2006.Erlotinib Side Effects Report #5290184-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ejection fraction decreased, pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5307884-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 06, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5565819-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Male patient, 76 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, TOPROL, LIPITOR, NIASPAN, NITROSTAT, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5391740-9
Erlotinib side effect was reported by a Health Professional from ISRAEL on June 30, 2005. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastroenteritis
, hypokalaemia, pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with MERCAPTOPURINE, BEZAFIBRATE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5487271-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 28, 2007. Male patient, 72 years of age, weighting 236.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, VITAMIN, ATENOLOL, AMICAR, CALCIUM. Patient recovered.Erlotinib Side Effects Report #5504062-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2007. Male patient, 72 years of age, weighting 236.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, pulmonary embolism
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, VITAMIN, ATENOLOL, AMICAR. Patient recovered.Erlotinib Side Effects Report #5897686-1
Erlotinib side effect was reported by a Physician from BELGIUM on Sept 08, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, hypoxia, pulmonary embolism . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with TOUXIUM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6032155-X
Erlotinib side effect was reported by a Health Professional from CZECH REPUBLIC on Dec 23, 2008. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL, 150 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, ALIMTA, TAXOL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5834866-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 05, 2008. Female patient, 70 years of age, weighting 126.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: oedema peripheral, pulmonary embolism
. Erlotinib dosage: 100MG PO QD. During the same period patient was treated with CLINDAMYCIN, TRIAMCINOLONE. Patient recovered.Erlotinib Side Effects Report #6060244-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchopneumonia, cardiac failure congestive, malignant neoplasm progression, mucosal inflammation, non-small cell lung cancer, pleural effusion, pulmonary embolism
, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, LACTULOSE, DOMPERIDONE, DIGOXIN, DILTIAZEM, FUROSEMIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/17/2008.Erlotinib Side Effects Report #6140975-6
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
. Erlotinib dosage: (150 MG, QD FOR 12 DAYS, EVERY 21 DAYS), ORAL. During the same period patient was treated with TAXOTERE. Patient died on 02/07/2009.Erlotinib Side Effects Report #5578147-6
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Dec 18, 2007. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: international normalised ratio increased, prothrombin time prolonged, pulmonary embolism
. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5681114-5
Erlotinib side effect was reported by a Physician from ITALY on Mar 13, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: agitation, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient died on 02/12/2008.Erlotinib Side Effects Report #5259638-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 60 years of age, weighting 154.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5277740-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 05, 2007. Male patient, 60 years of age, weighting 154.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: eating disorder
, fall , pain , pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5313144-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Male patient, 60 years of age, weighting 154.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fall
, oral intake reduced, pain , pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with GABAPENTIN, ALBUTEROL, ZOLOFT, ATIVAN, TUSSIONEX. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5634049-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, pulmonary hypertension . Erlotinib dosage: unknown. Patient died.Erlotinib Side Effects Report #5729766-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 16, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5979490-9
Erlotinib side effect was reported by a Physician from FRANCE on Nov 13, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory failure, deep vein thrombosis
, pulmonary embolism . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SANDOZ, DEXERYL, PREDNISONE, XANAX, OMEPRAZOLE, DOMPERIDONE, VENTOLINE, KETOCONAZOLE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5782719-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 05, 2008. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: balance disorder, cancer pain, incoherent, oedema, pulmonary embolism
, unresponsive to stimuli. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FUROSEMIDE, HYDROMORPHONE, PREGABALIN, MELOXICAM, POTASSIUM CHLORIDE, SENOKOT, SPIRONOLACTONE, TRIAMTERENE. Patient died.Erlotinib Side Effects Report #5138648-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 09, 2006. Female patient, 52 years of age, weighting 123.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, granulocytes abnormal, neutrophil count abnormal, pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, AMITRIPTYLINE, FLUOXETINE, SUMATRIPTAN SUCCINATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5407336-6
Erlotinib side effect was reported by a Physician from SWITZERLAND on July 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dizziness
, muscular weakness, pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DEXAMETHASONE. Patient died.Erlotinib Side Effects Report #4928113-6
Erlotinib side effect was reported by a Physician from SWITZERLAND on Feb 21, 2006. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dizziness
, fall , pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DEXAMETHASONE. Patient died.Erlotinib Side Effects Report #5869365-8
Erlotinib side effect was reported by a Health Professional from FRANCE on Aug 15, 2008. Male patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory failure, deep vein thrombosis
, pulmonary embolism . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with SANDOZ, DEXERYL, PREDNISONE, XANAX, MOPRAL, DOMPERIDONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5722247-4
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 48 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: unknown. Patient recovered.Erlotinib Side Effects Report #4808179-4
Erlotinib side effect was reported by a Consumer or non-health professional from FRANCE on Sept 26, 2005. Female patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: intracranial pressure increased, metastases to central nervous system, pulmonary embolism
. Erlotinib dosage: 150 MG/ ORAL. During the same period patient was treated with DEBRIDAT, DURAGESIC, XANAX. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5736920-5
Erlotinib side effect was reported by a Pharmacist from SAUDI ARABIA on Apr 25, 2008. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, productive cough, pulmonary embolism
, tachycardia, tachypnoea. Erlotinib dosage: (150 MG, QD) , ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5643835-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5918103-9
Erlotinib side effect was reported by a Physician from ITALY on Sept 24, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient died on 09/02/2008.Erlotinib Side Effects Report #6112614-1
Erlotinib side effect was reported by a Physician from BOSNIA AND HERZEGOWINA on Feb 24, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: (150 MG, QD), ORAL. Patient died.Erlotinib Side Effects Report #6128181-2
Erlotinib side effect was reported by a Pharmacist from ITALY on Mar 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5832823-6
Erlotinib side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on July 17, 2008. Female patient, 68 years of age, weighting 97.00 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aspartate aminotransferase increased, diarrhoea, fatigue, hypoalbuminaemia, laboratory test abnormal, pulmonary embolism
, pulmonary infarction, thrombocytopenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FUROSEMIDE, METOPROLOL TARTRATE, CALTRATE PLUS. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #6140770-8
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DOCETAXEL, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6099533-4
Erlotinib side effect was reported by a Health Professional from FRANCE on Feb 11, 2009. Male patient, 39 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: phlebitis, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died on 10/21/2008.Erlotinib Side Effects Report #5844659-0
Erlotinib side effect was reported by a Physician from JAPAN on Aug 01, 2008. Male patient, 66 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RABEPRAZOLE, GABAPEN, ASPIRIN, WARFARIN. Patient recovered.Erlotinib Side Effects Report #5365800-2
Erlotinib side effect was reported by a Physician from UNITED STATES on June 04, 2007. Female patient, 64 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: loss of consciousness, pulmonary embolism
. Erlotinib dosage: 150 MG (QD); ORAL. Patient died on 05/31/2007.Erlotinib Side Effects Report #5729634-9
Erlotinib side effect was reported by a Physician from JAPAN on Apr 16, 2008. Female patient, 63 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, pulmonary embolism
, venous thrombosis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient died on 04/02/2008.Erlotinib Side Effects Report #5803937-1
Erlotinib side effect was reported by a Physician from JAPAN on June 19, 2008. Female patient, 63 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient died on 04/02/2008.Erlotinib Side Effects Report #5721522-7
Erlotinib side effect was reported by a Physician from JAPAN on Apr 14, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, pulmonary embolism
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, MUCOSTA, ETODOLAC, MAGNESIUM OXIDE. Patient recovered.Erlotinib Side Effects Report #5878592-5
Erlotinib side effect was reported by a Physician from JAPAN on Aug 26, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, decreased appetite, pulmonary embolism
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, MUCOSTA, ETODOLAC, MAGNESIUM OXIDE. Patient recovered.Erlotinib Side Effects Report #5732113-6
Erlotinib side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, hepatic function abnormal, immobile, interstitial lung disease, nail disorder, no therapeutic response, pulmonary embolism
, pulmonary hypertension , pulse absent. Erlotinib dosage: (150 MG QD), ORAL. During the same period patient was treated with PREDNISOLONE, NIFEDIPINE, LOSARTAN POTASSIUM, FENOFIBRATE, DEPAS, RABEPRAZOLE, GASMOTIN, BASEN. Patient died on 01/23/2008.Erlotinib Side Effects Report #5763455-6
Erlotinib side effect was reported by a Physician from JAPAN on May 20, 2008. Male patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, brain natriuretic peptide increased, disease progression, fibrin d dimer increased, liver disorder, pulmonary embolism
, pulmonary hypertension . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LIPITOR, DILTIAZEM HYDROCHLORIDE, NORVASC, FAMOTIDINE, ASPIRIN, LENDORM, NAIXAM, MS CONTIN. Patient recovered.Erlotinib Side Effects Report #5900767-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 12, 2008. Female patient, 48 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pulmonary embolism , pulmonary hypertension , right ventricular failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MUCOSTA, SUCRALFATE, PANTOSIN, MAGNESIUM OXIDE, HIRUDOID, METHADERM, NEO MEDROL, FENTANYL. Patient recovered.Erlotinib Side Effects Report #5933365-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 10, 2008. Male patient, 76 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, disease progression, pulmonary embolism . Erlotinib dosage: (50 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 10/01/2008.Erlotinib Side Effects Report #5958889-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Male patient, 76 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, hepatic neoplasm malignant, hypophagia, ill-defined disorder, malignant neoplasm progression, pulmonary embolism . Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DURAGESIC, CARDIZEM, COUMADIN, HYDROCHLOROTHIAZIDE, LANOXIN, LOPRESSOR. Patient died on 10/01/2008.Erlotinib Side Effects Report #5916947-0
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2008. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, pulmonary embolism . Erlotinib dosage: (50 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, DARVON, MEGACE, GELCLAIR. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5934958-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2008. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aortic valve incompetence, atrial fibrillation
, oedema peripheral, pulmonary embolism , pulmonary valve incompetence, tricuspid valve incompetence. Erlotinib dosage: 50 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, DARVON, MEGACE, GELCLAIR. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5455913-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Female patient, 64 years of age, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with LETROZOLE, NEXIUM, COMPAZINE, FERROUS SULPHATE, LORTAB. Patient died on 08/14/2007.Erlotinib Side Effects Report #5307863-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 06, 2007. Male patient, 48 years of age, weighting 97.66 lb, was diagnosed with anaplastic astrocytoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 500 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PHENYTOIN, DEXAMETHASONE, PANTOPRAZOLE, ESCITALOPRAM OXALATE, LEVETIRACETAM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6132582-6
Erlotinib side effect was reported by a Physician from FRANCE on Mar 09, 2009. Male patient, 64 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with PERINDOPRIL ERBUMINE, SECTRAL, PREDNISONE, KARDEGIC, PLAVIX, TRANXENE, NEXIUM, ATORVASTATIN CALCIUM. Patient recovered.Erlotinib Side Effects Report #5736877-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, lymphadenopathy, platelet count decreased, pulmonary embolism
. Erlotinib dosage: (100 MG, QD), ORAL. Patient recovered.Erlotinib Side Effects Report #5766203-9
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, platelet count decreased, pulmonary embolism
. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with LIPITOR, ZOFRAN, COMPAZINE, CLINDAMYCIN, DECADRON, LASIX, NASONEX, OXYCONTIN. Patient recovered.